Cover Image

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines

Inactivated coronavirus disease 2019 (COVID-19) vaccines such as CoronaVac and BBIBP-CorV have been widely used in China. However, more investigation is still needed to understand antibodies' duration and effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ziyu Liu (Author), Liyan Cai (Author), Man Xing (Author), Nan Qiao (Author), Jiaojiao Liu (Author), Xuejun Li (Author), Chiyu Zhang (Author), Naijun Tang (Author), Zhelong Xu (Author), Yingying Guo (Author), Renfei Lu (Author), Dongming Zhou (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers
by: Nataniel Tandirogang, et al.
Published: (2023)

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals
by: Yandong Cheng, et al.
Published: (2022)

How to Increase the Immunogenicity of SARS-COV-2 Inactivated Vaccines?
by: Yousef Khadivi
Published: (2021)

Increased body mass index linked to decreased neutralizing antibody titers of inactivated SARS‐CoV‐2 vaccine in healthcare workers
by: Juan Hu, et al.
Published: (2023)

VITT with inactivated SARS-CoV-2 vaccine - index case
by: Kanta Devi, et al.
Published: (2022)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022)

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection
by: Wujun Chen, et al.
Published: (2022)

Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
by: Kento Tazawa, et al.
Published: (2023)

Significant increase in anti-SARS-CoV-2 antibodies after administration of heterologous mRNA-based vaccine booster in individuals receiving two doses of inactivated COVID-19 vaccine: A single-center study in healthcare workers in Jakarta, Indonesia
by: Wuryantari Setiadi, et al.
Published: (2023)

Maternal-derived antibodies hinder the antibody response to H9N2 AIV inactivated vaccine in the field
by: Xue Pan, et al.
Published: (2022)

In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse
by: Manjunath Shet, et al.
Published: (2022)

Ozone Treatment Is Insufficient to Inactivate SARS-CoV-2 Surrogate under Field Conditions
by: Natalia Mazur-Panasiuk, et al.
Published: (2021)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
by: Zhao WM, et al.
Published: (2022)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial
by: Yongliang Feng, et al.
Published: (2021)

No Effect of Inactivated SARS-CoV-2 Vaccination on in vitro Fertilization Outcomes: A Propensity Score-Matched Study
by: Huang J, et al.
Published: (2022)

Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
by: Yao J, et al.
Published: (2021)

Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study
by: Yajie Gong, et al.
Published: (2023)

Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus
by: Lucas Campos Garcia, et al.
Published: (2023)

Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
by: Ting Zhao, et al.
Published: (2022)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
by: Tao-Hsin Tung, et al.
Published: (2022)

Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2
by: Hesti L. Wiraswati, et al.
Published: (2022)

The impact of sample processing on the rapid antigen detection test for SARS-CoV-2: Virus inactivation, VTM selection, and sample preservation
by: Haiwei Zhou, et al.
Published: (2021)

Levels of antibodies to SARS-CoV-2 at key time points during the COVID-19 pandemic in China
by: Liu Lina, et al.
Published: (2023)

Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques
by: Li Qin, et al.
Published: (2022)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
by: Ahmet Soysal, et al.
Published: (2021)

Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
by: Qi Lv, et al.
Published: (2021)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
by: Lairun Jin, et al.
Published: (2022)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
by: Shuyu Gao, et al.
Published: (2022)

Waning antibodies to SARS-CoV-2 - Don't panic
by: Benjamin Meyer
Published: (2021)

Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
by: Rong Tang, et al.
Published: (2019)

Detectable antibodies against SARS-CoV-2 in newborns from mothers infected with COVID-19 at different gestational ages
by: Huaheng Mo, et al.
Published: (2021)

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
by: Rima R. Sahay, et al.
Published: (2022)

Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination
by: Ruyun Gao, et al.
Published: (2023)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
by: Marc-Kendy Paul, et al.
Published: (2024)

Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational studyResearch in context
by: Alejandro Jara, et al.
Published: (2023)

Comparison of the SARS-CoV-2-inactivating activities of the differently manufactured hypochlorous acid water products with various pH
by: Yohei Takeda, et al.
Published: (2021)

Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes
by: Xiaoying Zhou, et al.
Published: (2023)

Suspended cell lines for inactivated virus vaccine production
by: Jiayou Zhang, et al.
Published: (2023)